BPGAM
XLRN

BTG Pactual Global Asset Management’s Acceleron Pharma XLRN Stock Holding History

BTG Pactual Global Asset Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,000
Closed -$688K – 165
2021
Q3 		$688K Buy
+4,000
New +$523K 0.12% 126

BTG Pactual Global Asset Management's XLRN Position: Q4 2021 in Review

BTG Pactual Global Asset Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 4,000 shares — an estimated $688K sold.

BTG Pactual Global Asset Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $688K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • BTG Pactual Global Asset Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • BTG Pactual Global Asset Management sold 4,000 Acceleron Pharma shares in Q4 2021, an estimated $688K.
  • BTG Pactual Global Asset Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • BTG Pactual Global Asset Management's Acceleron Pharma position peaked at $688K in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on BTG Pactual Global Asset Management's 13F filing for Q4 2021, filed 9 Feb 2022.